-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $494

Benzinga·10/30/2026 20:57:39
Listen to the news
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.